| Literature DB >> 21126606 |
Emily Jane Woo1, Robert P Wise, David Menschik, Sean V Shadomy, John Iskander, Judy Beeler, Frederick Varricchio, Robert Ball.
Abstract
We reviewed thrombocytopenia (TP) reports to the US Vaccine Adverse Event Reporting System (VAERS). We examined TP patterns for differences in single versus multiple immunization reports, presence of a live viral vaccine, seriousness, age, and interval to symptom onset. We found 1510 reports of possible TP and after exclusions evaluated 1440 for possible causes. Most (1078; 75%) met the regulatory definition of a serious adverse event. TP was reported after inactivated and live viral vaccines. Platelet counts <10×10(9)/L were reported. Identified vaccines could be prioritized for hypothesis-testing studies. Published by Elsevier Ltd.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21126606 DOI: 10.1016/j.vaccine.2010.11.051
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641